UniProt ID | ACK1_MOUSE | |
---|---|---|
UniProt AC | O54967 | |
Protein Name | Activated CDC42 kinase 1 | |
Gene Name | Tnk2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1055 | |
Subcellular Localization |
Cell membrane. Nucleus. Endosome. Cell junction, adherens junction. Cytoplasmic vesicle membrane Peripheral membrane protein Cytoplasmic side. Cytoplasmic vesicle, clathrin-coated vesicle. Membrane, clathrin-coated pit. The Tyr-284 phosphorylated f |
|
Protein Description | Non-receptor tyrosine-protein and serine/threonine-protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr-287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR.. | |
Protein Sequence | MQPEEGTGWLLELLSEVQLQQYFLRLRDDLNITRLSHFEYVKNEDLEKIGMGRPGQRRLWEAVKRRKAMCKRKSWMSKVFSGKRLEAEFPSQHSQSTFRKPSPTPGSLPGEGTLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPAGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTLPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMAYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIEGRAENYWWRGQNTRTLCVGPFPRNVVTSVAGLSAQDISQPLQNSFIHTGHGDSDPRHCWGFPDRIDELYLGNPMDPPDLLSVELSTSRPTQHLGRVKREPPPRPPQPAIFTQKTTYDPVSEDPDPLSSDFKRLGLRKPALPRGLWLAKPSARVPGTKADRSSGGEVTLIDFGEEPVVPTPRPCAPSLAQLAMDACSLLDKTPPQSPTRALPRPLHPTPVVDWDARPLPPPPAYDDVAQDEDDFEVCSINSTLVGAGLPAGPSQGETNYAFVPEQAQMPPALEDNLFLPPQGGGKPPSSVQTAEIFQALQQECMRQLQVPTGQLTPSPTPGGDDKPQVPPRVPIPPRPTRPRVELSPAPSGEEETSRWPGPASPPRVPPREPLSPQGSRTPSPLVPPGSSPLPHRLSSSPGKTMPTTQSFASDPKYATPQVIQAPGPRAGPCILPIVRDGRKVSSTHYYLLPERPPYLERYQRFLREAQSPEEPAALPVPPLLPPPSTPAPAAPTATVRPMPQAAPDPKANFSTNNSNPGARPPSLRAAARLPQRGCPGDGQEAARPADKVQMLQAMVHGVTTEECQAALQSHSWSVQRAAQYLKVEQLFGLGLRPRVECHKVLEMFDWNLEQAGCHLLGSCGPAHHKR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Phosphorylation | LRDDLNITRLSHFEY HHCCCCCCCCCCEEE | 25.20 | 22817900 | |
40 | Phosphorylation | TRLSHFEYVKNEDLE CCCCCEEEECCHHHH | 18.77 | 15582259 | |
94 | Phosphorylation | AEFPSQHSQSTFRKP EECCCCCCCCCCCCC | 20.42 | 26060331 | |
96 | Phosphorylation | FPSQHSQSTFRKPSP CCCCCCCCCCCCCCC | 32.31 | 26060331 | |
97 | Phosphorylation | PSQHSQSTFRKPSPT CCCCCCCCCCCCCCC | 21.59 | 26060331 | |
102 | Phosphorylation | QSTFRKPSPTPGSLP CCCCCCCCCCCCCCC | 44.43 | 26824392 | |
104 | Phosphorylation | TFRKPSPTPGSLPGE CCCCCCCCCCCCCCC | 44.62 | 25619855 | |
107 | Phosphorylation | KPSPTPGSLPGEGTL CCCCCCCCCCCCCCH | 32.37 | 25619855 | |
113 | Phosphorylation | GSLPGEGTLQSLTCL CCCCCCCCHHHHHEE | 19.81 | 21082442 | |
116 | Phosphorylation | PGEGTLQSLTCLIGE CCCCCHHHHHEEECH | 28.85 | 25619855 | |
118 | Phosphorylation | EGTLQSLTCLIGEKD CCCHHHHHEEECHHH | 15.54 | 25619855 | |
131 | Ubiquitination | KDLRLLEKLGDGSFG HHHHHHHHHCCCCCE | 58.71 | - | |
284 | Phosphorylation | LPQNDDHYVMQEHRK CCCCCCCCCCCCCCC | 12.47 | 20623637 | |
430 | Phosphorylation | YWWRGQNTRTLCVGP CEECCCCCCEEEECC | 19.69 | 22871156 | |
517 (in isoform 2) | Phosphorylation | - | 48.50 | 22499769 | |
517 (in isoform 3) | Phosphorylation | - | 48.50 | 22499769 | |
518 (in isoform 2) | Phosphorylation | - | 32.55 | 22499769 | |
518 (in isoform 3) | Phosphorylation | - | 32.55 | 22499769 | |
522 (in isoform 2) | Phosphorylation | - | 54.81 | 22499769 | |
522 (in isoform 3) | Phosphorylation | - | 54.81 | 22499769 | |
528 | Phosphorylation | PPQPAIFTQKTTYDP CCCCCCEECCCCCCC | 24.04 | 52677249 | |
529 (in isoform 2) | Phosphorylation | - | 30.28 | 22499769 | |
529 (in isoform 3) | Phosphorylation | - | 30.28 | 22499769 | |
530 (in isoform 2) | Phosphorylation | - | 39.51 | 22499769 | |
530 (in isoform 3) | Phosphorylation | - | 39.51 | 22499769 | |
532 | Phosphorylation | AIFTQKTTYDPVSED CCEECCCCCCCCCCC | 32.72 | 8572385 | |
533 | Phosphorylation | IFTQKTTYDPVSEDP CEECCCCCCCCCCCC | 24.39 | 21169560 | |
565 | Ubiquitination | PRGLWLAKPSARVPG CCCCEECCCCCCCCC | 37.02 | - | |
567 | Phosphorylation | GLWLAKPSARVPGTK CCEECCCCCCCCCCC | 28.18 | 28066266 | |
578 | Phosphorylation | PGTKADRSSGGEVTL CCCCCCCCCCCCEEE | 33.60 | 25338131 | |
579 | Phosphorylation | GTKADRSSGGEVTLI CCCCCCCCCCCEEEE | 52.27 | 25338131 | |
613 | Phosphorylation | QLAMDACSLLDKTPP HHHHHHHHHHCCCCC | 33.42 | 26643407 | |
618 | Phosphorylation | ACSLLDKTPPQSPTR HHHHHCCCCCCCCCC | 39.61 | 26643407 | |
622 | Phosphorylation | LDKTPPQSPTRALPR HCCCCCCCCCCCCCC | 33.73 | 31437595 | |
624 | Phosphorylation | KTPPQSPTRALPRPL CCCCCCCCCCCCCCC | 33.55 | 21743459 | |
650 | Phosphorylation | PLPPPPAYDDVAQDE CCCCCCCCCCCCCCC | 20.60 | 8502309 | |
737 | Phosphorylation | MRQLQVPTGQLTPSP HHHCCCCCCCCCCCC | 38.41 | 21183079 | |
741 | Phosphorylation | QVPTGQLTPSPTPGG CCCCCCCCCCCCCCC | 17.52 | 9396461 | |
743 | Phosphorylation | PTGQLTPSPTPGGDD CCCCCCCCCCCCCCC | 35.85 | 5640681 | |
772 | Phosphorylation | TRPRVELSPAPSGEE CCCCEEEECCCCCCC | 12.90 | 25521595 | |
776 | Phosphorylation | VELSPAPSGEEETSR EEEECCCCCCCCCCC | 62.03 | 25619855 | |
789 | Phosphorylation | SRWPGPASPPRVPPR CCCCCCCCCCCCCCC | 38.27 | 21082442 | |
800 | Phosphorylation | VPPREPLSPQGSRTP CCCCCCCCCCCCCCC | 26.37 | 26824392 | |
804 | Phosphorylation | EPLSPQGSRTPSPLV CCCCCCCCCCCCCCC | 27.94 | 28066266 | |
806 | Phosphorylation | LSPQGSRTPSPLVPP CCCCCCCCCCCCCCC | 29.80 | 26643407 | |
808 | Phosphorylation | PQGSRTPSPLVPPGS CCCCCCCCCCCCCCC | 30.19 | 26824392 | |
815 | Phosphorylation | SPLVPPGSSPLPHRL CCCCCCCCCCCCCCC | 34.26 | 25338131 | |
816 | Phosphorylation | PLVPPGSSPLPHRLS CCCCCCCCCCCCCCC | 36.05 | 26370283 | |
823 | Phosphorylation | SPLPHRLSSSPGKTM CCCCCCCCCCCCCCC | 28.82 | 28285833 | |
824 | Phosphorylation | PLPHRLSSSPGKTMP CCCCCCCCCCCCCCC | 45.18 | 28066266 | |
825 | Phosphorylation | LPHRLSSSPGKTMPT CCCCCCCCCCCCCCC | 34.00 | 45560515 | |
832 | O-linked_Glycosylation | SPGKTMPTTQSFASD CCCCCCCCCCHHCCC | 27.01 | 30059200 | |
833 | O-linked_Glycosylation | PGKTMPTTQSFASDP CCCCCCCCCHHCCCC | 19.15 | 30059200 | |
842 | Phosphorylation | SFASDPKYATPQVIQ HHCCCCCCCCCCEEE | 22.54 | 25521595 | |
844 | Phosphorylation | ASDPKYATPQVIQAP CCCCCCCCCCEEECC | 15.91 | 25619855 | |
854 | Methylation | VIQAPGPRAGPCILP EEECCCCCCCCEEEE | 59.08 | 24129315 | |
870 | Phosphorylation | VRDGRKVSSTHYYLL EECCEEEECCEEECC | 32.33 | 22499769 | |
871 | Phosphorylation | RDGRKVSSTHYYLLP ECCEEEECCEEECCC | 23.38 | 22499769 | |
872 | Phosphorylation | DGRKVSSTHYYLLPE CCEEEECCEEECCCC | 13.34 | 22499769 | |
874 | Phosphorylation | RKVSSTHYYLLPERP EEEECCEEECCCCCC | 8.90 | 18515860 | |
875 | Phosphorylation | KVSSTHYYLLPERPP EEECCEEECCCCCCH | 8.31 | 22499769 | |
883 | Phosphorylation | LLPERPPYLERYQRF CCCCCCHHHHHHHHH | 24.71 | 22499769 | |
887 | Phosphorylation | RPPYLERYQRFLREA CCHHHHHHHHHHHHC | 8.48 | - | |
896 | Phosphorylation | RFLREAQSPEEPAAL HHHHHCCCCCCCCCC | 41.13 | 8570647 | |
943 | Phosphorylation | ANFSTNNSNPGARPP CCCCCCCCCCCCCCH | 46.61 | 29472430 | |
951 | Phosphorylation | NPGARPPSLRAAARL CCCCCCHHHHHHHCC | 32.92 | 26824392 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
284 | Y | Phosphorylation | Kinase | SRC | P05480 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACK1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACK1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CLH1_MOUSE | Cltc | physical | 21169560 | |
PSMD1_MOUSE | Psmd1 | physical | 17182860 | |
PSMD6_MOUSE | Psmd6 | physical | 17182860 | |
NCK1_MOUSE | Nck1 | physical | 16777958 | |
UBC_MOUSE | Ubc | physical | 17182860 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Constitutive activated Cdc42-associated kinase (Ack) phosphorylationat arrested endocytic clathrin-coated pits of cells that lackdynamin."; Shen H., Ferguson S.M., Dephoure N., Park R., Yang Y.,Volpicelli-Daley L., Gygi S., Schlessinger J., De Camilli P.; Mol. Biol. Cell 22:493-502(2011). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT TYR-284 AND TYR-533. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-533 AND TYR-874, ANDMASS SPECTROMETRY. |